Laval University-ko ikertzaileekin lankidetzan egindako argitalpenak (23)

2024

  1. Anti-KIF20B autoantibodies are associated with cranial neuropathy in systemic lupus erythematosus

    Lupus Science and Medicine, Vol. 11, Núm. 1

  2. Remission and low disease activity are associated with lower healthcare costs: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort

    Annals of the Rheumatic Diseases

2023

  1. Fluctuation of Anti–Domain 1 and Anti–β2-Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies

    Arthritis and Rheumatology, Vol. 75, Núm. 6, pp. 984-995

2022

  1. Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort

    Annals of the rheumatic diseases, Vol. 81, Núm. 3, pp. 370-378

  2. Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine

    Lupus Science and Medicine, Vol. 9, Núm. 1

2020

  1. Construction of a frailty index as a novel health measure in systemic lupus erythematosus

    Journal of Rheumatology, Vol. 47, Núm. 1, pp. 72-81

  2. Economic Evaluation of Damage Accrual in an International Systemic Lupus Erythematosus Inception Cohort Using a Multistate Model Approach

    Arthritis Care and Research, Vol. 72, Núm. 12, pp. 1800-1808

  3. Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study

    Arthritis and Rheumatology, Vol. 72, Núm. 1, pp. 67-77

  4. Prediction of Damage Accrual in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index

    Arthritis and Rheumatology, Vol. 72, Núm. 4, pp. 658-666

  5. Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus

    Journal of Autoimmunity, Vol. 106

2019

  1. Antinuclear Antibody–Negative Systemic Lupus Erythematosus in an International Inception Cohort

    Arthritis Care and Research, Vol. 71, Núm. 7, pp. 893-902

  2. Evaluating the Properties of a Frailty Index and Its Association With Mortality Risk Among Patients With Systemic Lupus Erythematosus

    Arthritis and Rheumatology, Vol. 71, Núm. 8, pp. 1297-1307

  3. Osteopontin and disease activity in patients with recent-onset systemic Lupus Erythematosus: Results from the SLICC Inception Cohort

    Journal of Rheumatology, Vol. 46, Núm. 5, pp. 492-500

  4. Psychosis in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study

    Arthritis and Rheumatology, Vol. 71, Núm. 2, pp. 281-289

  5. The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody–Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository

    Arthritis Care and Research, Vol. 71, Núm. 1, pp. 134-141

  6. The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort

    Seminars in Arthritis and Rheumatism, Vol. 49, Núm. 3, pp. 464-468

2018

  1. Economic Evaluation of Lupus Nephritis in the Systemic Lupus International Collaborating Clinics Inception Cohort Using a Multistate Model Approach

    Arthritis Care and Research, Vol. 70, Núm. 9, pp. 1294-1302

  2. Study of Flare Assessment in Systemic Lupus Erythematosus Based on Paper Patients

    Arthritis Care and Research, Vol. 70, Núm. 1, pp. 98-103

2015

  1. Anti-C1q antibodies in systemic lupus erythematosus

    Lupus, Vol. 24, Núm. 1, pp. 42-49

2014

  1. Lymphoma risk in systemic lupus: Effects of disease activity versus treatment

    Annals of the Rheumatic Diseases, Vol. 73, Núm. 1, pp. 138-142